Investing Profile

Colleen Cuffaro

VCInvestor
Partner at Canaan Partners
canaan.com/team/colleen-cuffa...New Haven, Connecticut
Photo of Colleen Cuffaro, Partner at Canaan Partners
University of Pennsylvania Network
143 CONNECTIONS
Canaan Partners Network
15 CONNECTIONS
cb
$250K - $20.0M
$10.0M
10
$800M
CompanyStageDateRound SizeTotal Raised
CatalYm
Series DJul 2024$150M
$200M
Co-investors: Marianne Uteng (Novartis Venture Fund), Oscar Slotboom (BGV (BioGeneration Ventures)), Jonathan Tobin (Brandon Capital Partners), Nathalie Weitemeyer (Bayern Kapital), Rogier Rooswinkel (Forbion), Jon Edwards (Red Tree Venture Capital)
AgomAb Therapeutics
Series COct 2023$100M
$200M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital)
Comet Therapeutics
Series AJun 2019$29M
$29M
Co-investors: Roel Bulthuis (INKEF Capital), Henrijette Richter (Soffinova Partners)
Arrakis Therapeutics
Series BApr 2019$75M
Series AFeb 2017$38M
$110M
Co-investors: Richard Gaster (venBio), Jakob Loven (Nextech Invest)
NextCure
Series BNov 2018$93M
Series AJan 2016$67M
$160M
Co-investors: Tim Shannon (Canaan Partners), David Kabakoff (HealthQuest Capital)
Arvinas
Series CApr 2018$55M
Series BOct 2015$42M
Series ASep 2013$15M
$140M
Co-investors: Stephen Squinto (OrbiMed), Kush Parmar (5am Ventures), Tim Shannon (Canaan Partners), Liam Ratcliffe (Access Biotechnology), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest), Daniel Wagner (Connecticut Innovations), Martin Alexander Gershon (Endeavor Venture Funds)
Associate Canaan Partners2014 - Present
Bio Sciences Analyst Entrepreneurship Lab NYC2012 - 2013
Analytical Chemist PMRS Inc2006 - 2009
Yale University School of Medicine PhD Cellular and Molecular Physiology
University of Pennsylvania BA Chemistry